This is a Phase 3 clinical research study for adults with pulmonary hypertension associated with interstitial lung disease, also called PH-ILD. The study will compare an investigational inhaled drug called treprostinil palmitil inhalation powder, or TPIP, with placebo. Participants will be assigned by chance to receive TPIP or placebo once daily for 24 weeks. The main purpose is to determine whether TPIP improves how far participants can walk in six minutes and whether it delays worsening of PH-ILD. Participants will complete study visits, physical examinations, blood tests, heart and lung testing, questionnaires, and six-minute walk tests. Participation may last up to approximately 32 weeks, including screening, treatment, and follow-up. An optional hemodynamic sub-study will include an additional right heart catheterization near the end of study treatment for eligible participants who separately consent.
Young adults who smoke are at a high risk of developing tobacco-related diseases and cancers. Young adults are also less likely to quit smoking than older adults, and having a parent who also smokes can make quitting even harder. This study looks at how family relationships affect smoking and quitting among young adults ages 18 to 29 who smoke every day and have a parent who currently smokes. In the first phase of this study, young adults will complete online surveys about their smoking habits and their relationship with their parent. In the second phase, some of those young adults and their parents will take part in one-on-one interviews to talk about how their relationship affects smoking and quitting. All study activities will be done remotely. What researchers learn will help guide the development of a future program that helps young adults and their parents quit smoking together.
This Research study is collecting blood samples with the goal to develop a blood based test that may help detect lung cancer at the earliest stage. the test will look for genetic clues in the blood that may be associated with lung cancer. A minimally invasive blood test could potentially provide additional information along side the standard of care image screening methods used for lung cancer screening.
This Research study is collecting blood samples with the goal to develop a blood based test that may help detect lung cancer at the earliest stage. the test will look for genetic clues in the blood that may be associated with lung cancer. A minimally invasive blood test could potentially provide additional information along side the standard of care image screening methods used for lung cancer screening.
This Research study is collecting blood samples with the goal to develop a blood based test that may help detect lung cancer at the earliest stage. the test will look for genetic clues in the blood that may be associated with lung cancer. A minimally invasive blood test could potentially provide additional information along side the standard of care image screening methods used for lung cancer screening.
This Research study is collecting blood samples with the goal to develop a blood based test that may help detect lung cancer at the earliest stage. the test will look for genetic clues in the blood that may be associated with lung cancer. A minimally invasive blood test could potentially provide additional information along side the standard of care image screening methods used for lung cancer screening.
This Research study is collecting blood samples with the goal to develop a blood based test that may help detect lung cancer at the earliest stage. the test will look for genetic clues in the blood that may be associated with lung cancer. A minimally invasive blood test could potentially provide additional information along side the standard of care image screening methods used for lung cancer screening.
This Research study is collecting blood samples with the goal to develop a blood based test that may help detect lung cancer at the earliest stage. the test will look for genetic clues in the blood that may be associated with lung cancer. A minimally invasive blood test could potentially provide additional information along side the standard of care image screening methods used for lung cancer screening.
This Research study is collecting blood samples with the goal to develop a blood based test that may help detect lung cancer at the earliest stage. the test will look for genetic clues in the blood that may be associated with lung cancer. A minimally invasive blood test could potentially provide additional information along side the standard of care image screening methods used for lung cancer screening.
This study will examine how medications called GLP-1 receptor agonists should be managed before an upper endoscopy. Participants taking a weekly GLP-1 receptor agonist will be randomly assigned to continue their medication, stop it for 7 days before the procedure, or stop it for 14 days before the procedure. Before the endoscopy, an ultrasound will be used to assess the amount and type of contents remaining in the stomach. The study will compare the groups to determine how different medication hold times affect the amount of stomach contents present at the time of endoscopy. The results may help inform future recommendations for managing GLP-1 receptor agonists before endoscopic procedures.